Comments received stock index 3100 points to protect the public and private equity aimed at the phar 下北glory days

Comments received: stock index 3100 points to protect the public and private equity in the fourth quarter of the pharmaceutical industry to focus on the hot stream of thousands of shares of the stock of thousands of shares to review the latest rating simulation trading client We want you! The first 2016 China Potter Rockefeller award officially started! Funds, insurance, brokerage and other financial institutions, information management capabilities which is better? Please click [vote], select the strongest institutions in your heart! Sina Financial News on October 31st, the stock index risk guard 3100 points. As of the close, the stock index at 3100.49 points, down 0.12%, entrepreneurship blackboard 2159.76 points, down 0.26%. Classification fund, the 304 venue grading fund, 74 rose, down only 196. A resource led to a 4.44% increase to 5.23%, and 300A led the decline. The public offering aimed at the pharmaceutical industry the four quarter since the three quarter, A stock market continued sideways, and quiet for a long time, but by virtue of the pharmaceutical sector than expected performance, set off a wave of structural market. Including SDIC UBS, star stone investment, including a number of private equity funds have said, A shares have formed a value of depression, the next investment tuyere is the pharmaceutical industry. The latest statistics show that the end of the three quarter, the public fund investment in health and social work market value of 11 billion 6 million yuan, the market value of investments and the end of the two quarter compared with an increase of 12.47%; investment fund market value of total investment in the stock market than is 0.49%, the relative standard industry allocation ratio with the super 0.3 percentage points. More than 75 fund companies, 70 companies of the industry are overweight, accounted for 93.33%. Star Stone Investment chief strategist Liu Ke said on October 27th, for the current A-share market, is a good time to configure the value of the strategic value of the A, and the next real growth opportunities lie in the pharmaceutical industry. He believes that the overall valuation of A shares market and November 2008 level, at the bottom of the historical valuation range, has become the largest category of asset allocation value depression, the market may usher in the domestic real estate market and the bond market "spillover effect" of liquidity inflection point. In the context of A shares by domestic and foreign investors concerned, the value of the shares will become a strategic choice for investors, through this year’s core driver is to improve profitability. Liu Ke said that the pharmaceutical industry is the opportunity to configure the structure of the industry. Based on the judgment and the judgment of the liquor is very similar, are the relationship between supply and demand changes, the same optimistic about the benefits of the policy, the trend of prosperity to the leading enterprises in the sub sectors. Star Stone Investment believes that the influence of the pharmaceutical industry development trend and investment opportunities of the biggest catalyst or policy factors: the first half of 2016, heavy medicine policy introduced into the landing stage gradually, have a significant impact on the whole industry structure; the government will also position the pharmaceutical industry reached a hitherto unknown height. In addition, restricting the pharmaceutical industry over the past few years the development of the medical insurance cost control, has been gradually approaching the policy objectives, controlling health care costs, a negative impact on the entire industry will be gradually eliminated in the next 1 years to 2 years, then the whole industry is expected to usher in a turning point. theory相关的主题文章: